curasan AG
Description Curasan AG develops, manufactures, and markets regenerative medicinal products and services in Germany and internationally. It offers products in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal, and orthopaedic applications. The company provides Cerasorb Ortho, a synthetic bone regeneration material for use in physiological defect treatment; Cerasorb M Ortho, Cerasorb Ortho block forms, and CERASORB Ortho FOAM for filling, bridging, and/or reconstruction of resected non-infected bony defects, as well as plastic reconstruction of damaged or resected bone, and filling of intervertebral implants; stypro, a biomaterial developed to aid haemostasis; and Curavisc, which reduces pain and improves joint mobility. It also offers Osgide, a biodegradable barrier membrane for use in guided tissue regeneration and guided bone regeneration; Osbone, a synthetic hydroxyapatite bone substitute material for bone void filling, bone augmentation, and implantation; and advanced tissue regeneration-curasan set, a single use device to extract autologous platelet-mediator concentrate for accelerated and improved healing in bone and tissue regeneration. The company sells its products through contractual partners. The company was founded in 1988 and is based in Kleinostheim, Germany. To view the detailed information, you need to SUBSCRIBE with us. |
 |